miR-21 promotes non-small cell lung cancer cells growth by regulating fatty acid metabolism
Authors:
Open Access
- 23 August 2019
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 19 (1) , 1-10
Abstract
Lung cancer is one of the most common malignant tumors worldwide. CD36 is a receptor for fatty acids and plays an important role in regulating fatty acid metabolism, which is closely related to tumorigenesis and development. The regulation of miR-21 and its role in tumorigenesis have been extensively studied in recent years. However, the relationship between miR-21 and CD36 regulated fatty acid metabolism in human non-small cell lung cancer remains unknown. In this study, lentivirus transfection, qRT-PCR, cell migration, immunofluorescence, and western blot were used to examine the relationship between miR-21 and CD36 regulated fatty acid metabolism and the regulation role of miR-21 in human non-small cell lung cancer. This study demonstrated that up-regulation of miR-21 promoted cell migration and cell growth in human non-small cell lung cancer cells. Moreover, the intracellular contents of lipids including cellular content of phospholipids, neutral lipids content, cellular content of triglycerides were significantly increased following miR-21 mimic treatment compared with control, and the levels of key lipid metabolic enzymes FASN, ACC1 and FABP5 were obviously enhanced in human non-small cell lung cancer cells. Furthermore, down-regulation of CD36 suppressed miR-21 regulated cell growth, migration and intracellular contents of lipids in human non-small cell lung cancer cells, which suggested that miR-21 promoted cell growth and migration of human non-small cell lung cancer cells through CD36 mediated fatty acid metabolism. Inhibition of miR-21 was revealed to inhibit cell growth, migration, intracellular contents of lipids, and CD36 protein expression level in human non-small cell lung cancer cells. In addition, PPARGC1B was a direct target of miR-21, and down-regulation of PPARGC1B reversed the inhibition of CD36 expression induced by miR-21 inhibitor. These results explored the mechanism of miR-21 promoted non-small cell lung cancer and might provide a novel therapeutic method in treating non-small cell lung cancer in clinic.Keywords
Funding Information
- This project is funded by Zhejiang Provincial Lung Cancer Diagnosis and Treatment Technology Research Center
This publication has 40 references indexed in Scilit:
- The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung CancerFrontiers in Oncology, 2015
- Structure-Function of CD36 and Importance of Fatty Acid Signal Transduction in Fat MetabolismAnnual Review of Nutrition, 2014
- Effect of Polyunsaturated Fatty Acids on Homocysteine Metabolism through Regulating the Gene Expressions Involved in Methionine MetabolismThe Scientific World Journal, 2013
- Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary Epithelial Cells Partly via Stimulation of MiR-21PLOS ONE, 2012
- Short-Chain Fatty Acids Induce Apoptosis in Colon Cancer Cells Associated with Changes to Intracellular Redox State and Glucose MetabolismChemotherapy, 2012
- miR-21 inhibitor sensitizes human OSCC cells to cisplatinMolecular Biology Reports, 2012
- Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acidsBritish Journal of Nutrition, 2012
- Role of CD36 in Oral and Postoral Sensing of Lipids2011
- Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancerJournal of Biomedical Research, 2010
- Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer CellsJournal of Biological Chemistry, 2008